Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Services
  • Preclinicalサービス
    • Preclinicalサービス
    • Revvity Omics Services
    • 臨床サービス
    • Customization Services
    • Viral Vector Engineering and Manufacture
    • Instrument Service & Maintenance
    • ライセンシング
    • Customer Training
    • OEM ソリューション
  • Preclinical Multiomics Services
    • 抗体薬物複合体(ADC)サービス
    • 抗体医薬品向け非臨床サービス
    • 複雑な細胞モデルを用いたスクリーニングサービス
    • 塩基編集プラットフォーム
    • 免疫細胞スクリーニング
    • 機能ゲノミクススクリーニングサービス
    • 細胞パネルスクリーニング
    • 遺伝子改変細胞株作製受託サービス
    • Viral Vector Engineering and Manufacture
    • Preclinical Multiomics Services
Preclinical Multiomics Services

Preclinical Multiomics Services

Integrated multiomics. Deeper insights. Smarter decisions.

Gain deeper insights to support confident decision-making with our preclinical multiomics services. Our phenomics, genomics, transcriptomics, and proteomics capabilities provide the breadth and depth of data for a more complete picture, so you can confidently select compounds, train AI-models, and advance your drug discovery program.
 

Contact us

Why choose Revvity's multiomics services?

  • Get quality, AI-ready multiomics data that provide a more complete picture of phenotypic and molecular function to support smarter decisions
  • Combine cell viability, phenomics, genomics, transcriptomics, and proteomics readouts for information-rich datasets to build complex datasets, train machine-learning models, and generate actionable insights
  • Access our broad range of over 600 cell lines, including primary immune cells
  • Use bulk or single-cell technologies to align assay design with your drug discovery needs and budget
  • Support from our experienced scientific team with assay design and data interpretation
  • Flexibility to accommodate your specific requirements and project timelines

Quality, AI-ready data - expertly delivered.

Known for its scientific rigor, our preclinical services team provides you with quality AI-ready data to support your AI-driven drug discovery that is:

  • Standardized and traceable with consistent identifiers and data collection records
  • Annotated with relevant metadata tailored to the data type and analysis needs
  • Structured to support computational analysis, machine learning, and data integration
  • Flexible to client requirements, including custom data and annotation standards

Your partner for multiomics data with the breadth to reveal and depth to decide.

Revvity's multiomics capabilities cover cell viability, phenomics, genomics, transcriptomics, and proteomics to generate impactful datasets for deeper biological insight.

Our preclinical multiomics services generate information-rich datasets from a range of orthogonal readouts that can be integrated to provide deeper biological insight and support better decision-making.

Learn about our multiomics services

Cell viability services

Cell viability services

Measure cell health, survival and proliferation with our range of cell-based assays, including ATP-based readouts.

Measure cell health, survival and proliferation with our range of cell-based assays, including ATP-based readouts.

  • Viability assay data for a foundational understanding of your compound’s cytotoxicity and efficacy
  • Choose 2D or 3D ATP-based assays generated using our ATPlite™ 1glow technology, with additional readouts to assess metabolism-related mechanisms of action
  • Combine viability data with phenotypic, genomic, transcriptomic, and proteomic data for a deeper understanding of cellular function and interactions

Contact us for further details and to discuss how we can support you.

Contact us
Phenomics services

Phenomics services

Gain deeper insights into cellular biology and cell behaviour by analyzing phenotypic changes with our high-content imaging and cell painting capabilities.

Gain deeper insights into cellular biology and cell behaviour by analyzing phenotypic changes with our high-content imaging and cell painting capabilities.

  • Benefit from Revvity’s extensive imaging and screening expertise as the developer of the Opera Phenix OptIQ™ and Operetta CLS™ imagers, PhenoVue™ reagents, and Harmony™ and Signals™ software
  • High-content screens tailored to your specific research needs and delivered using the Opera Phenix™ HCS system
  • Support a range of assays, including cell health, cell morphology, protein localization, and complex model growth
  • Complements transcriptomics data to understand why a phenotype emerged and which genes orchestrate it

Contact us for further details and to discuss how we can support your goals.

Contact us

Learn more how Revvity can help your drug development with the following resources:

Application Note

Combining high-content imaging and DRUG-seq to improve Mechanism-of-Action profiling

Learn more
Application Note

Effectiveness of CRISPR-Cas9 using pools of Dharmacon™ Edit-R™ synthetic crRNAs in high-content analysis screening experiments

Learn more
Genomics services

Genomics services

Analyze at the DNA level to better understand biological interactions, pathways, gene regulation networks, and the molecular basis of phenotypes with our technology and expertise.

Analyze at the DNA level to better understand biological interactions, pathways, gene regulation networks, and the molecular basis of phenotypes with our technology and expertise.

  • Extensive experience in arrayed and pooled Functional Genomic Screening across broad panels of cell lines and a range of cell types
  • CRISPRko, CRISPRi, CRISPRa, Pin-point™ base editing, and RNAi screens tailored to your application
  • Small molecules, biologics, or oligonucleotide therapeutics can be added to screens to understand drug-gene interactions and drug mechanism of action
  • Whole genome, targeted, and tiled libraries tailored to your assay question
  • Combine genomics and phenomics data to reveal how the genome impacts expression, modification, and interactions of proteins

Contact us today to book a consultation with our team to discuss how we can help accelerate your projects.

Contact us

Learn more how Revvity can help your drug development with the following resources:

Application Note

CRISPRsc: Pooled CRISPR screening with single-cell transcriptome resolution

Learn more
Application Note

The dual screen: Parallel genome-wide CRISPRi and CRISPRa screening

Learn more
Application Note

Dual-guide CRISPR Cas9-knockout screening for gene‑gene interaction analysis and beyond.

Learn more
Revvity’s transcriptomics services. RNA molecule.

Transcriptomics services

Gain a deeper understanding of gene expression with pathway-level and mechanism-of-action (MoA) insights that complement phenotypic screening using transcriptomics.

Gain a deeper understanding of gene expression with pathway-level and mechanism-of-action (MoA) insights that complement phenotypic screening using transcriptomics.

  • Partner with us to generate RNA-level data using the MERCURIUS™ DRUG-seq high-throughput transcriptomics technology.
  • Build higher resolution data with single-cell RNAseq technologies
  • Generate gene expression signatures at screening scale to support drug-target and functional genomics workflows, hit prioritization, and MoA studies.
  • Combine transcriptomic and morphological profiling to create richer perturbation datasets that help explain phenotypic changes and investigate underlying mechanisms.
  • Generate higher-resolution data with single-cell RNA-seq technologies.

Contact us for further details and to discuss how we can advance your project.

Contact us

Learn more how Revvity can help your drug development with the following resources:

Application Note

Combining high-content imaging and DRUG-seq to improve Mechanism-of-Action profiling.

Learn more
Revvity’s proteomics services. Protein molecule.

Proteomics services

Enhance transcriptomics workflows by integrating protein detection to gain additional insights into gene expression, regulation, and cellular interactions.

Enhance transcriptomics workflows by integrating protein detection to gain additional insights into gene expression, regulation, and cellular interactions.

  • Enable single-cell multiomics by integrating protein and transcriptomic profiling using CITE-seq to add protein-level context to cellular function, response mechanisms, and target biology.
  • Generate data on protein expression, post-translational modifications (PTMs), and signaling networks.
  • Understand how protein expression relates to transcriptomic data in single-cell assays.
  • Combine protein measurements with other multiomics data types to support interpretation of genotype-phenotype relationships.

Contact us for further details and to discuss how we can support your goals.

Contact us

Featured resources

Application Note

Combining high-content imaging and DRUG-seq to improve Mechanism-of-Action profiling.

Learn more
Application Note

Dual-guide CRISPR Cas9-knockout screening for gene‑gene interaction analysis and beyond.

Learn more
Application Note

Machine-learning prediction of drug mechanism of action from high-content cell painting images

Learn more

You may also be interested in

Cell panel screening services thumbnail

細胞パネルスクリーニング

<strong>OncoSignatureスクリーニングサービスによる、2Dまたは3Dフォーマットでの300種類以上の標準がん細胞株のスクリーニングを通じた、治療薬に応答する細胞の同定</strong>
Learn more
Functional Genomic Screening Services

機能ゲノミクススクリーニングサービス

機能ゲノミクススクリーニングサービスを活用して、創薬標的の同定と特性評価を行いましょう。CRISPRノックアウト、CRISPR転写活性化、CRISPR転写抑制、Dualスクリーニング、RNAi技術を提供しています。
Learn more
immune-cell-screening512x288

免疫細胞スクリーニング

標的同定とリード最適化のための生物学的に関連する問題を解決するために、ヒト初代免疫細胞を使用した非臨床スクリーニングサービス
Learn more
全てを表示 View less
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2026 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.

Scroll Icon